Renaissance Technologies - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 48 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2018$206,000
-15.2%
332,333
+77.6%
0.00%
Q3 2018$243,000
+71.1%
187,100
+78.0%
0.00%
Q2 2018$142,000105,1000.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,699,848$15,687,0002.68%
Northeast Financial Consultants Inc 732,265$3,105,0001.31%
WEDBUSH SECURITIES INC 15,000$64,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 148,054$628,0000.01%
THRIVENT FINANCIAL FOR LUTHERANS 413,278$1,752,0000.01%
Virtu KCG Holdings LLC 72,989$309,0000.01%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 35,555$151,0000.00%
WILLIAMS JONES & ASSOCIATES LLC 15,100$64,0000.00%
BlackRock Fund Advisors 612,231$2,596,0000.00%
Spot Trading L.L.C 15,000$64,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders